Groowe Groowe / Newsroom / TEVA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TEVA News

Teva Pharmaceutical Industries Limited American Depositary Shares

Teva to Present at the Goldman Sachs Global Healthcare Conference

globenewswire.com
TEVA

Form 8-K

sec.gov
TEVA TEVJF

Interact Enters a New Era of Growth with Brand Evolution, AI Innovation, and Industry Recognition

globenewswire.com
LEVI DPZ TEVA

Medincell to Participate in Jefferies and Evercore Investor Conferences in the U.S. in June

businesswire.com
TEVA

CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research

prnewswire.com
AMGN LLY TEVA PFE ABBV

The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults

globenewswire.com
TEVA

Interact Advances its Agentic AI Vision with Content Moderation, Cross-System Search, and Workday Workflows

globenewswire.com
DPZ TEVA

Polymyositis Market Research Report 2026-2036: Competitive Landscape is Dominated by Major Players Such As Teva Pharmaceuticals, Gilead Sciences, Roche, AbbVie, and Pfizer

globenewswire.com
TEVA GILD ABBV PFE

Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution

globenewswire.com
TEVA

Carella Byrne Cecchi Brody Agnello, P.C. Announce a Class Action Settlement If You Paid for, Purchased, or Provided Reimbursement For a Drug Which Contained Metformin From July 20, 2015 through June 2, 2020

prnewswire.com
TEVA